[{"NetIncomeLoss_1_Q1_USD":-3126800.0,"GeneralAndAdministrativeExpense_1_Q1_USD":1390600.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":51321355.0,"CommitmentsAndContingencies_0_Q1_USD":null,"RepaymentsOfLongTermCapitalLeaseObligations_1_Q1_USD":800.0,"LiabilitiesNoncurrent_0_Q1_USD":9105500.0,"AccruedLiabilitiesCurrent_0_Q1_USD":607800.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q1_USD":1931400.0,"OperatingLeasesRentExpenseNet_1_Q1_USD":3500.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":0.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":50000.0,"CapitalLeasedAssetsGross_0_Q1_USD":14700.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":726000.0,"AssetsCurrent_0_Q1_USD":2178900.0,"TreasuryStockShares_0_Q1_shares":135665.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":42766174.0,"TreasuryStockValue_0_Q1_USD":3968100.0,"ConvertibleDebtNoncurrent_0_Q1_USD":124700.0,"CapitalLeaseObligationsCurrent_0_Q1_USD":3400.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":668400.0,"CapitalLeasesLesseeBalanceSheetAssetsByMajorClassAccumulatedDeprecation_0_Q1_USD":10100.0,"CommonStockSharesIssued_0_Q1_shares":55937472.0,"DepreciationAndAmortization_1_Q1_USD":25400.0,"OperatingLeaseLiability_0_Q1_USD":3956800.0,"Liabilities_0_Q1_USD":11778600.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":3631100.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":488000.0,"ClassOfWarrantOrRightOutstanding_0_Q1_shares":26589834.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":5368800.0,"InterestPayableCurrentAndNoncurrent_0_Q1_USD":400.0,"PaymentsOfFinancingCosts_1_Q1_USD":29400.0,"PrepaidExpenseCurrent_0_Q1_USD":633000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":2400.0,"CommonStockValue_0_Q1_USD":55900.0,"LongTermNotesPayable_0_Q1_USD":124700.0,"ProceedsFromIssuanceOrSaleOfEquity_1_Q1_USD":2790600.0,"StockIssuedDuringPeriodValueIssuedForServices_1_Q1_USD":125000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-434400.0,"CashAndCashEquivalentsPeriodIncreaseDecrease_1_Q1_USD":190800.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q1_USD":1731200.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":2997500.0,"StockIssuedDuringPeriodValueOther_1_Q1_USD":2747500.0,"ConvertibleDebtCurrent_0_Q1_USD":100100.0,"OtherPrepaidExpenseCurrent_0_Q1_USD":1600.0,"ProceedsFromNotesPayable_1_Q1_USD":224400.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-3462600.0,"OtherAssetsNoncurrent_0_Q1_USD":47800.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":1545900.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q1_USD":789000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":194600.0,"AdjustmentsToAdditionalPaidInCapitalOther_1_Q1_USD":-29400.0,"ShareBasedCompensation_1_Q1_USD":674600.0,"CapitalLeaseObligationsNoncurrent_0_Q1_USD":2100.0,"DividendsPreferredStockCash_1_Q1_USD":335800.0,"PreferredStockDividendsAndOtherAdjustments_1_Q1_USD":335800.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":1061900.0,"NotesAndLoansPayableCurrent_0_Q1_USD":428900.0,"InterestIncomeExpenseNet_1_Q1_USD":-3200.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":674600.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2806700.0,"ConvertibleNotesPayable_0_Q1_USD":428500.0,"LiabilitiesCurrent_0_Q1_USD":2673100.0,"AccountsPayableCurrent_0_Q1_USD":1307300.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":633000.0,"IncreaseDecreaseInOtherReceivables_1_Q1_USD":0.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":16100.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0854,"IncreaseDecreaseInOtherOperatingAssets_1_Q1_USD":-87500.0,"AdditionalPaidInCapital_0_Q1_USD":203330700.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":12600.0,"PrepaidInsurance_0_Q1_USD":391200.0,"CapitalLeasesBalanceSheetAssetsByMajorClassNet_0_Q1_USD":4600.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":184200.0,"DividendsPreferredStock_1_Q1_USD":335800.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-205034200.0,"IncreaseDecreaseInOtherOperatingLiabilities_1_Q1_USD":-72200.0,"OtherIncome_1_Q1_USD":600.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3492100.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":62600.0,"RepaymentsOfNotesPayable_1_Q1_USD":49900.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":1412000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q1_USD":766000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-39200.0,"CommonStockSharesAuthorized_0_Q1_shares":175000000.0,"OperatingIncomeLoss_1_Q1_USD":-3121800.0,"Assets_0_Q1_USD":6166900.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-3124400.0,"OperatingLeaseCost_1_Q1_USD":212800.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":6166900.0,"PreferredStockSharesAuthorized_0_Q1_shares":10000000.0,"PropertyPlantAndEquipmentGross_0_Q1_USD":1246100.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":325700.0,"OperatingExpenses_1_Q1_USD":3121800.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.07,"ProfitLoss_1_Q1_USD":-3126800.0,"DeferredOfferingCosts_0_Q1_USD":263900.0,"StockholdersEquity_0_Q1_USD":-5611700.0,"CommonStockOtherSharesOutstanding_0_Q1_shares":55937472.0,"ConvertibleDebt_0_Q1_USD":428900.0,"Ticker":"VTGN","CIK":"1411685","name":"VISTAGEN THERAPEUTICS, INC.","OfficialName":"VistaGen Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"309791933.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200813"}]